Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Abstract Emphasizing the significance of cancer-associated fibroblasts (CAFs), non-malignant yet pivotal players within the tumor microenvironment (TME), this review illuminates the role of inflammatory subtype (iCAF) as catalysts in cancer proliferation, metastasis, and therapeutic resistance. Give...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Cancer Nanotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12645-024-00302-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832594972870705152 |
|---|---|
| author | Zhongsong Zhang Long Chen |
| author_facet | Zhongsong Zhang Long Chen |
| author_sort | Zhongsong Zhang |
| collection | DOAJ |
| description | Abstract Emphasizing the significance of cancer-associated fibroblasts (CAFs), non-malignant yet pivotal players within the tumor microenvironment (TME), this review illuminates the role of inflammatory subtype (iCAF) as catalysts in cancer proliferation, metastasis, and therapeutic resistance. Given their paramount importance, targeting CAFs emerges as a robust strategy in the evolving landscape of cancer immunotherapy. Nanomaterials, distinguished by their unique features and malleability, hold considerable promise in biomedicine, especially in the precision-oriented domain of cancer therapy. Their aptitude for modulating immune responses, amplifying drug efficacy through precise delivery, and discerningly focusing on cells within the TME situates nanomaterials as formidable tools to transcend the boundaries set by conventional treatments. This review scrutinizes the convoluted interplay among CAFs, immune cells, and tumor cells within the TME. It further showcases widely utilized nanomaterials in cancer management. We underscore the potential of nanoscale drug delivery systems directed at CAFs, underscoring their transformative power in revolutionizing cancer therapies, enhancing precision, and culminating in improved patient outcomes. |
| format | Article |
| id | doaj-art-5d9a377b8e264647a61ae48ef9d44acd |
| institution | Kabale University |
| issn | 1868-6958 1868-6966 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Cancer Nanotechnology |
| spelling | doaj-art-5d9a377b8e264647a61ae48ef9d44acd2025-01-19T12:10:28ZengBMCCancer Nanotechnology1868-69581868-69662025-01-0116114110.1186/s12645-024-00302-1Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblastsZhongsong Zhang0Long Chen1School of Clinical Medicine, Chengdu Medical CollegeSchool of Clinical Medicine, Chengdu Medical CollegeAbstract Emphasizing the significance of cancer-associated fibroblasts (CAFs), non-malignant yet pivotal players within the tumor microenvironment (TME), this review illuminates the role of inflammatory subtype (iCAF) as catalysts in cancer proliferation, metastasis, and therapeutic resistance. Given their paramount importance, targeting CAFs emerges as a robust strategy in the evolving landscape of cancer immunotherapy. Nanomaterials, distinguished by their unique features and malleability, hold considerable promise in biomedicine, especially in the precision-oriented domain of cancer therapy. Their aptitude for modulating immune responses, amplifying drug efficacy through precise delivery, and discerningly focusing on cells within the TME situates nanomaterials as formidable tools to transcend the boundaries set by conventional treatments. This review scrutinizes the convoluted interplay among CAFs, immune cells, and tumor cells within the TME. It further showcases widely utilized nanomaterials in cancer management. We underscore the potential of nanoscale drug delivery systems directed at CAFs, underscoring their transformative power in revolutionizing cancer therapies, enhancing precision, and culminating in improved patient outcomes.https://doi.org/10.1186/s12645-024-00302-1Cancer-associated fibroblastsDrug deliveryNanomedicineTumor microenvironmentCancer immunotherapy |
| spellingShingle | Zhongsong Zhang Long Chen Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts Cancer Nanotechnology Cancer-associated fibroblasts Drug delivery Nanomedicine Tumor microenvironment Cancer immunotherapy |
| title | Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts |
| title_full | Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts |
| title_fullStr | Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts |
| title_full_unstemmed | Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts |
| title_short | Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts |
| title_sort | nanomaterials in cancer immunotherapy targeting cancer associated fibroblasts |
| topic | Cancer-associated fibroblasts Drug delivery Nanomedicine Tumor microenvironment Cancer immunotherapy |
| url | https://doi.org/10.1186/s12645-024-00302-1 |
| work_keys_str_mv | AT zhongsongzhang nanomaterialsincancerimmunotherapytargetingcancerassociatedfibroblasts AT longchen nanomaterialsincancerimmunotherapytargetingcancerassociatedfibroblasts |